Juvenile Idiopathic Arthritis is one of the most common chronic conditions in children, and the Joint Injection Program is providing improved and faster access to one of the most effective treatments.
The program began in the fall of 2012 and is run by Drs. Tania Cellucci and Michelle Batthish, Assistant Professors in the Division of Rheumatology. Before the program was introduced, pateints would have to see more specialists and wait longer for treatment, sometimes up to three months. The Joint Injection Program streamlines the process: Cellucci and Batthish are able to provide this treatment directly to children and teenagers with arthritis, sometimes in as little as one week. It also offers the opportunity for patients to receive unsedated treatments right in the clinic setting, and reduces the number of hospital visits for the family.
On average, this new program treats around three patients per month, administering injections to provide relief for inflammatory arthritis. (Pictured Above, L-R: Drs. Tania Cellucci and Michelle Batthish)
"Families who have been through both the old and new systems have provided a lot of positive feedback about the new program," comments Cellucci. "The process is strealined, less stressful, and injections happen faster. It may not be a large program, but it has enhanced the quality of care that we provide and it is meaningful to our families and the patients we treat."